BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37803110)

  • 1. Systems Biology Approach to Analyze Microarray Datasets for Identification of Disease-Causing Genes: Case Study of Oral Squamous Cell Carcinoma.
    Choubey J; Wolkenhauer O; Chatterjee T
    Methods Mol Biol; 2024; 2719():13-31. PubMed ID: 37803110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.
    Lin YC; Chen BS
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of differentially expressed lncRNAs in the pathogenesis of oral squamous cell carcinoma.
    Zhang S; Tian L; Ma P; Sun Q; Zhang K; GuanchaoWang ; Liu H; Xu B
    Arch Oral Biol; 2015 Oct; 60(10):1581-7. PubMed ID: 26276270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
    Zhang YY; Mao MH; Han ZX
    Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating multiple microarray datasets on oral squamous cell carcinoma to reveal dysregulated networks.
    Liu Z; Niu Y; Li C; Yang Y; Gao C
    Head Neck; 2012 Dec; 34(12):1789-97. PubMed ID: 22179951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
    Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
    J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MKI67 an potential oncogene of oral squamous cell carcinoma via the high throughput technology.
    Liu ZM; Bao Y; Li TK; Di YB; Song WJ
    Medicine (Baltimore); 2022 Dec; 101(52):e32595. PubMed ID: 36596059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a six-gene prognostic signature for oral squamous cell carcinoma.
    Wang J; Wang Y; Kong F; Han R; Song W; Chen D; Bu L; Wang S; Yue J; Ma L
    J Cell Physiol; 2020 Mar; 235(3):3056-3068. PubMed ID: 31538341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 10. Porphyromonas gingivalis Activation of Tumor-Associated Macrophages via DOK3 Promotes Recurrence of Oral Squamous Cell Carcinoma.
    Li CX; Su Y; Gong ZC; Liu H
    Med Sci Monit; 2022 Oct; 28():e937126. PubMed ID: 36210538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers.
    Huang J; Meng Q; Liu R; Li H; Li Y; Yang Z; Wang Y; Wanyan C; Yang X; Wei J
    Clin Transl Oncol; 2023 Oct; 25(10):3006-3020. PubMed ID: 37029240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
    Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
    BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
    Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
    Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.
    Lee CH; Pan KL; Tang YC; Tsai MH; Cheng AJ; Shen MY; Cheng YM; Huang TT; Lin P
    Oncotarget; 2015 Sep; 6(28):25188-201. PubMed ID: 26317789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast gene expression profile reflects the stage of tumour progression in oral squamous cell carcinoma.
    Lim KP; Cirillo N; Hassona Y; Wei W; Thurlow JK; Cheong SC; Pitiyage G; Parkinson EK; Prime SS
    J Pathol; 2011 Mar; 223(4):459-69. PubMed ID: 21294120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal model and bioinformatics analyses suggest the TIMP1/MMP9 axis as a potential biomarker in oral squamous cell carcinoma.
    Xu G; Wei J; Huangfu B; Gao J; Wang X; Xiao L; Xuan R; Chen Z; Song G
    Mol Carcinog; 2020 Nov; 59(11):1302-1316. PubMed ID: 33006223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network pharmacology and bioinformatics analysis on the underlying mechanisms of baicalein against oral squamous cell carcinoma.
    Tang B; Dong Y
    J Gene Med; 2023 Jun; 25(6):e3490. PubMed ID: 36843559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Cross-Talk between Oral Squamous Cell Carcinoma and Type 2 Diabetes: The Potential Role of Immunity.
    Fan Y; Zhang J; Shi J; Chen L; Long J; Zhang S; Liu S
    Dis Markers; 2022; 2022():6389906. PubMed ID: 35634436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential druggable targets of cell cycle with small-molecule inhibitors in oral squamous cell carcinoma.
    Zhou X; Jin W; Chen Y; Zhu L; Mo A; Xie Q
    Pharmacogenet Genomics; 2022 Jun; 32(4):125-137. PubMed ID: 34954767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.